• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锰亚锗烯配合物:与氢气、异腈和氮气的反应活性。

Manganese germylene complexes: reactivity with dihydrogen, isonitriles, and dinitrogen.

作者信息

Price Jeffrey S, Emslie David J H

机构信息

Department of Chemistry, McMaster University, 1280 Main St West, Hamilton, Ontario, L8S 4M1, Canada.

出版信息

Dalton Trans. 2025 Jun 24;54(25):9949-9968. doi: 10.1039/d5dt01025j.

DOI:10.1039/d5dt01025j
PMID:40495789
Abstract

The manganese germylene-hydride complexes [(dmpe)MnH(GeR)] (1a: R = Ph, 1b: R = Et) reacted with H (approx. 1.5 atm) to afford the 'germyl dihdyride' species [(dmpe)MnH(GeHR)] (2a: R = Ph, 2b: R = Et) as an equilibrium mixture with the starting material (1a-b). In solution, 2a-b exist as a mixture of isomers where the major isomer (71-84%) is a hydrogermane hydride complex -[(dmpe)MnH(HGeHR)] (transHGe-2a-b). The minor isomer of 2a-b is tentatively assigned as the germyl dihydrogen complex -[(dmpe)Mn(GeHR)(H)] (cis-2a-b), possibly in rapid equilibrium with a small amount of the germanate complex [(dmpe)Mn(HGeHR)] (central-2a-b). DFT calculations were employed to gain insight into the nature of bonding in the isomers of 2a-b, and an X-ray crystal structure was obtained for -[(dmpe)MnH(HGeHEt)] (transHGe-2b) which co-crystallized with 1b. Reactions of 1a-b with D suggest a pathway that proceeds conversion of 1a-b to a 5-coordinate germyl intermediate [(dmpe)Mn(GeHR)] (A) prior to reaction with H/D. Providing support for this pathway, intermediate A (R = Ph) was trapped reactions of 1a with isonitriles, affording the manganese(I) germyl isonitrile complexes [(dmpe)Mn(GeHPh)(CNR)] (3a: R = Bu, 3b: R = -xylyl, and 3c: R = Bu). These complexes formed as a mixture of and isomers, and X-ray quality crystals were obtained for cis-3a, cis-3b and trans-3c. Complexes 1a-b also reacted slowly with dinitrogen at room temperature to afford germyl dinitrogen complexes [(dmpe)Mn(GeHR)(N)] (5a: R = Ph, 5b: R = Et). Compounds 5a-b were initially formed as isomers, but the isomer is the thermodynamic product in each case, and the and isomers were crystallographically characterized for both 5a and 5b. X-ray crystallography, IR spectroscopy, and DFT calculations were employed to compare metal-dinitrogen bonding in the and isomers of 5a-b. The silyl dinitrogen derivative [(dmpe)Mn(SiHPh)(N)] (6) was also generated as a mixture of the and isomers, and the isomer was structurally characterized. The isomers of 5b and 6 show Mn-P coupling in the P{H} and Mn{H} NMR spectra, affording 1 : 1 : 1 : 1 : 1 : 1 sextets and 1 : 4 : 6 : 4 : 1 quintets, respectively.

摘要

锰锗烯氢化物配合物[(dmpe)MnH(GeR)](1a:R = 苯基,1b:R = 乙基)与氢气(约1.5个大气压)反应,得到“锗基二氢化物”物种[(dmpe)MnH(GeHR)](2a:R = 苯基,2b:R = 乙基),它与起始原料(1a - b)形成平衡混合物。在溶液中,2a - b以异构体混合物形式存在,其中主要异构体(71 - 84%)是氢化锗氢配合物-[(dmpe)MnH(HGeHR)](反式HGe - 2a - b)。2a - b的次要异构体暂定为锗基二氢配合物-[(dmpe)Mn(GeHR)(H)](顺式-2a - b),可能与少量锗酸盐配合物[(dmpe)Mn(HGeHR)](中心式-2a - b)处于快速平衡。采用密度泛函理论(DFT)计算来深入了解2a - b异构体的键合性质,并获得了与1b共结晶的-[(dmpe)MnH(HGeHEt)](反式HGe - 2b)的X射线晶体结构。1a - b与氘的反应表明,在与H/D反应之前,存在一条将1a - b转化为五配位锗基中间体[(dmpe)Mn(GeHR)](A)的途径。为这条途径提供支持的是,中间体A(R = 苯基)通过1a与异腈的反应被捕获,得到锰(I)锗基异腈配合物[(dmpe)Mn(GeHPh)(CNR)](3a:R = 丁基,3b:R = -二甲苯基,3c:R = 丁基)。这些配合物以和异构体的混合物形式形成,并且获得了顺式-3a、顺式-3b和反式-3c的X射线优质晶体。配合物1a - b在室温下也与氮气缓慢反应,得到锗基二氮配合物[(dmpe)Mn(GeHR)(N)](5a:R = 苯基,5b:R = 乙基)。化合物5a - b最初以异构体形式形成,但异构体在每种情况下都是热力学产物,并且对5a和5b的异构体和异构体都进行了晶体学表征。采用X射线晶体学、红外光谱和DFT计算来比较5a - b异构体和异构体中的金属 - 二氮键合。硅基二氮衍生物[(dmpe)Mn(SiHPh)(N)](6)也以异构体混合物形式生成,并且对异构体进行了结构表征。5b和6的异构体在磷{氢}和锰{氢}核磁共振谱中显示锰 - 磷耦合,分别给出1∶1∶1∶1∶1∶1六重峰和1∶4∶6∶4∶1五重峰。

相似文献

1
Manganese germylene complexes: reactivity with dihydrogen, isonitriles, and dinitrogen.锰亚锗烯配合物:与氢气、异腈和氮气的反应活性。
Dalton Trans. 2025 Jun 24;54(25):9949-9968. doi: 10.1039/d5dt01025j.
2
Reactions of [(dmpe)MnH(CH)] with hydrogermanes to form germylene, germyl, hydrogermane, and germanide complexes.[(二甲基膦基乙烷)锰氢(甲基)]与氢化锗反应形成亚锗烯、锗基、氢化锗和锗化物配合物。
Dalton Trans. 2023 Oct 24;52(41):14880-14895. doi: 10.1039/d3dt02437g.
3
Interconversion and reactivity of manganese silyl, silylene, and silene complexes.锰硅基、硅烯和硅烯配合物的相互转化及反应活性
Chem Sci. 2019 Oct 29;10(47):10853-10869. doi: 10.1039/c9sc04513a. eCollection 2019 Dec 21.
4
Reactions of [(dmpe)MnH(CH)]: synthesis and characterization of manganese(i) borohydride and hydride complexes.[(dmpe)MnH(CH)]的反应:硼氢化锰(I)和氢化物配合物的合成与表征
Dalton Trans. 2020 Aug 7;49(29):9983-9994. doi: 10.1039/d0dt01726d. Epub 2020 Jul 6.
5
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.免疫调节剂和免疫抑制剂治疗复发缓解型多发性硬化症的网状 Meta 分析。
Cochrane Database Syst Rev. 2024 Jan 4;1(1):CD011381. doi: 10.1002/14651858.CD011381.pub3.
8
Manganese Silylene Hydride Complexes: Synthesis and Reactivity with Ethylene to Afford Silene Hydride Complexes.锰硅烷氢化物配合物的合成及其与乙烯的反应生成硅烯氢化物配合物。
Angew Chem Int Ed Engl. 2017 May 22;56(22):6223-6227. doi: 10.1002/anie.201700863. Epub 2017 Mar 15.
9
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.对首次出现提示多发性硬化症临床发作的患者使用疾病修饰药物进行治疗。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
10
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.